Related Experiment Video
Updated: Jul 20, 2026
08:45
Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Conjugated bile acid replacement therapy for short-bowel syndrome
C Gruy-Kapral1, K H Little, J S Fordtran
1Department of Medicine, Baylor University Medical Center, Dallas, Texas, 75246, USA.
Gastroenterology
|December 31, 1998
Summary
Bile acid replacement therapy improved fat absorption and weight in a short-bowel syndrome patient. This treatment for fat malabsorption did not worsen diarrhea, challenging previous beliefs.
Area of Science:
- Gastroenterology
- Metabolic Disorders
- Nutritional Science
Background:
- Short-bowel syndrome (SBS) causes fat malabsorption due to reduced bile acid secretion.
- Bile acid replacement therapy is avoided in SBS due to concerns of exacerbating diarrhea.
- This study investigated conjugated bile acid therapy in an SBS patient with an ileostomy.
Observation:
- The patient had severe malabsorption and was dependent on parenteral nutrition.
- Metabolic balance studies and a 4-month outpatient trial were conducted.
- Two types of conjugated bile acids were tested: natural ox bile mixture and synthetic cholylsarcosine.
Findings:
- Both bile acid preparations significantly increased fat absorption by approximately 40 g/day.
- Calcium absorption also improved with bile acid therapy.
- Neither therapy led to a significant increase in ileostomy output; the patient gained weight without adverse effects.
Implications:
- Conjugated bile acid replacement therapy can be beneficial for selected SBS patients.
- This challenges the contraindication of bile acid therapy in SBS.
- It offers a potential treatment to improve nutrient absorption and weight in SBS.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD: